Issues
- Current Issue
- Special Issues
Viewpoints
Education
Spotlight
News
Topic Compilations
On Location
Multimedia
- Sound Bites
- Meeting Coverage

Search

ASH Home
About ASH Clinical News
Authors
Advertising
Subscribe
Contact Us
eNewsletters

Cookie Settings

LOG IN

Welcome! Log into your account

Forgot your password?

Recover your password

ASH Clinical News

Issues
- All Current Issue Special Issues
  
  June 2021 Volume 7 Issue 7
  
  May 2021 Volume 7 Issue 6
  
  Focus on Myeloid Malignancies (Volume 7, Issue 6.1)
  
  April 2021 Volume 7 Issue 5
Viewpoints
Education
Spotlight
News
Topic Compilations
On Location
Multimedia
- Sound Bites
- Meeting Coverage

Generic selectors

Exact matches only

Exact matches only

Search in title

Search in title

Search in content

Search in content

Search in excerpt

Search in posts

Search in posts

Search in pages

Search in pages

Alison R. Walker, MD, MPH, MBA

Alison R. Walker, MD, MPH, MBA

Associate Professor in the Division of Hematology, The Ohio State University

Advertisement

Current Issue

June 2021 Volume 7 Issue 7

Tuesday, June 1, 2021

This issue reviews the management and prevention of peripheral neuropathy, early successes of SCD screening programs in sub-Saharan Africa, and more.

Block title

R-CHOP Versus R-EPOCH: No Difference in Survival for Patients With MYC-Rearranged, Double- or Triple-Hit...

Saturday, June 12, 2021

Investigators Identify Distinct Molecular Subgroups to Guide Treatment Decisions in AML

Saturday, June 12, 2021

Evaluating Enasidenib, With or Without Azacitidine, in Patients with IDH2-Mutated MDS

Saturday, June 12, 2021

Masking, Vaccination, and Research Needed to Protect Our Most Vulnerable Against COVID-19

Friday, June 11, 2021

Fixed-Duration Ibrutinib, Venetoclax Oral Combination Effective in CLL/SLL

Tuesday, June 8, 2021

Recent Posts

R-CHOP Versus R-EPOCH: No Difference in Survival for Patients With MYC-Rearranged, Double- or Triple-Hit DLBCL
Investigators Identify Distinct Molecular Subgroups to Guide Treatment Decisions in AML
Evaluating Enasidenib, With or Without Azacitidine, in Patients with IDH2-Mutated MDS
Masking, Vaccination, and Research Needed to Protect Our Most Vulnerable Against COVID-19

Meeting Coverage

Researchers Validate Burkitt Lymphoma Prognostic Index

Monday, March 1, 2021

Thiotepa-Containing Conditioning Regimens Improve Survival Outcomes in Patients With PCNSL

Monday, March 1, 2021

Editor's Corner

Editor’s Corner: It Takes a Village

Tuesday, June 1, 2021

Editor’s Corner: All Those YESterdays

Saturday, May 1, 2021

2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545

ASH Home
Research
Education
Advocacy
Meetings
Publications
ASH Store

Copyright © 2020 by American Society of Hematology

Contact Us | Terms of Service | Privacy Policy